Navigation Links
Target of diabetes type 1 identified,,

Researchers have identified a set of cells in the pancreas that are targeted by the white blood cells// and cause diabetes type 1.

The researchers from University of Colorado at Denver and Health Sciences Center says their research is likely to change the study of diabetes autoimmunity and may also change the way other autoimmune diseases are studied.

Diabetes type 1 is a metabolic disorder that happens due to rising levels of sugar in the blood, and mostly is due to defects in insulin secretion, insulin function or both. Type 1 diabetes is caused when specific cells that produce insulin in the pancreas are destroyed.

Previously it was thought that these cells might be of different varieties that exist at different locations in the pancreas. The new research suggests that these cells that gets destroyed are nothing but parts of the insulin itself, a peptide called B:9-23. The new concept of single target leads to possibilities that targeting this single peptide should cause the diabetes to be under control.

The research also brings to light the importance of insulin in the study of diabetes, and that of the insulin gene in causing diabetes across the generations.

The study is published in the current edition of journal Nature.

Reference: University of Colorado at Denver and Health Sciences Center, news release, May 2005
'"/>




Page: 1

Related medicine news :

1. Target for obesity treatment
2. Gel Offers A More Targeted Approach
3. In Search Of A New Drug To Target Cholesterol
4. In Search Of A New Drug To Target Cholesterol
5. Gene Target For Tuberculosis Identified
6. New Vaccine Targeted At Effective Treatment Against Tuberculosis
7. Novel Technique For Targeting Small-Cell Lung Cancer
8. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
9. Doctors, Pharma Companies Targeted By CBI Raids
10. Research Targets treatment for dementia and brain injuries
11. Cancer Treatments Fall Short Of Targets
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... 24, 2016 , ... People across the U.S. are sharpening their pencils and ... essay contest in which patients and their families pay tribute to a genetic counselor ... National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors Luke’s ... June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. ... helping service members that have been wounded in battle and their families. Venture Construction ...
(Date:6/24/2016)... ... 2016 , ... Finally, a bruise cream that really works. Originally designed ... into the post-surgical treatment plans of a variety of other procedures including, but not ... effective for bruising and causes a rapid resolution of bruising and inflammatory changes compared ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Today, InhaleLabs.com ... the ingestion of their medication by matching users with high quality water pipes within ... pieces with no commitment. , Inhale was founded by two brothers, Nick and Mike ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: